Numinus Wellness (NUMI.T) got the Health Canada nod to study ayahuasca and San Pedro at its research facility, Numinus Bioscience today. The license expansion works to boost NUMI’s profile as a recognized global… Read More
CHARLOTTETOWN, PE – The Canadian Alliance for Skills and Training in Life Sciences (CASTL) will proceed with establishing its first biopharmaceutical manufacturing training facility in Charlottetown, Prince Edward Island. Thanks… Read More
Health Canada license renewal expands Numinus’ extensive list of permissible R&D activities VANCOUVER, BC — Numinus Wellness Inc. (“Numinus” or the “Company”)(TSX: NUMI) (OTCQX: NUMIF), a mental healthcare company advancing… Read More
The de Boer Lab, whose current research is focused on understanding the logic and evolution of gene regulation, has just published a paper in Nature that offers an exciting new computer model,… Read More
First presentation of preclinical data for ESSA’s androgen receptor (AR) N-terminal domain degraders ANITen bAsed Chimera (ANITAC™) degraders degrade full length, mutant and splice variant forms of AR that are expressed… Read More
